Abstract
Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug is highly variable. Understanding the genetic contribution to metformin response might increase the possibility of personalising metformin treatment. We aimed to establish the heritability of glycaemic response to metformin using the genome-wide complex trait analysis (GCTA) method.
| Original language | English |
|---|---|
| Pages (from-to) | 481-487 |
| Journal | The Lancet Diabetes & Endocrinology |
| Volume | 2 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Subject classification (UKÄ)
- Endocrinology and Diabetes
Fingerprint
Dive into the research topics of 'Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver